Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2

INTRODUCTION: Psoriatic arthritis (PsA) has a major impact on health-related quality of life (HRQOL) and other patient-reported outcomes (PROs), important components in the assessment of therapeutic efficacy. We evaluated the impact of upadacitinib on PROs in PsA patients with inadequate responses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Van den Bosch, Filip, Ranza, Roberto, Leung, Ying-Ying, Drescher, Edit, Zueger, Patrick, Saffore, Christopher D., Lertratanakul, Apinya, Lippe, Ralph, Nash, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572272/
https://www.ncbi.nlm.nih.gov/pubmed/34661885
http://dx.doi.org/10.1007/s40744-021-00377-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572272/
https://www.ncbi.nlm.nih.gov/pubmed/34661885
http://dx.doi.org/10.1007/s40744-021-00377-x

Ejemplares similares